‘Highly revolutionary’: Newly FDA-approved gene modification has promise in cancer treatment – WTOP
WTOP |
'Highly revolutionary': Newly FDA-approved gene modification has promise in cancer treatment
WTOP The CAR–T cell treatment, developed by Novartis with multiple groups in the U.S. and internationally, is initially available to about 30 children's hospitals. Here's how it works: A patient donates blood that's shipped to the cell factory that … |
